Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Calza

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
AIDS (London, England)|September 28, 2002
A prospective case-control survey of laboratory markers of skeletal muscle damage during HIV disease and antiretroviral therapyRoberto Manfredi, Roberto Motta, Daniela Patrono, et al.
International Journal of STD & AIDS|June 14, 2003
Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapyLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Acta Dermato-Venereologica|September 30, 2005
Legionnaires' disease associated with macular rash: two casesLeonardo Calza, Elisabetta Briganti, Stefania Casolari, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2017
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settingsGiulia Cucchetto, Massimiliano Lanzafame, Stefano Nicolè, et al.
HIV Medicine|April 3, 2024
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gainLeonardo Calza, Maddalena Giglia, Vincenzo Colangeli, et al.
AIDS (London, England)|September 23, 2003
Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphomaRoberto Manfredi, Marina Tadolini, Lorenza Fortunato, et al.
Current HIV Research|November 11, 2008
Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitorsLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
AIDS Research and Human Retroviruses|June 19, 2023
Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 YearsLeonardo Calza, Vincenzo Colangeli, Giorgio Legnani, et al.
International Journal of STD & AIDS|March 10, 2026
Rectal carriage of antimicrobial resistant <i>Enterobacteriaceae</i> among MSM using HIV pre-exposure prophylaxis (PrEP): A cross-sectional study in ItalyLeonardo Calza, Marielle Ezekielle Djusse, Claudio Foschi, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2016
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
AIDS (London, England)|September 28, 2002
A prospective case-control survey of laboratory markers of skeletal muscle damage during HIV disease and antiretroviral therapyRoberto Manfredi, Roberto Motta, Daniela Patrono, et al.
International Journal of STD & AIDS|June 14, 2003
Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapyLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Acta Dermato-Venereologica|September 30, 2005
Legionnaires' disease associated with macular rash: two casesLeonardo Calza, Elisabetta Briganti, Stefania Casolari, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2017
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settingsGiulia Cucchetto, Massimiliano Lanzafame, Stefano Nicolè, et al.
HIV Medicine|April 3, 2024
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gainLeonardo Calza, Maddalena Giglia, Vincenzo Colangeli, et al.
AIDS (London, England)|September 23, 2003
Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphomaRoberto Manfredi, Marina Tadolini, Lorenza Fortunato, et al.
Current HIV Research|November 11, 2008
Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitorsLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
AIDS Research and Human Retroviruses|June 19, 2023
Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 YearsLeonardo Calza, Vincenzo Colangeli, Giorgio Legnani, et al.
International Journal of STD & AIDS|March 10, 2026
Rectal carriage of antimicrobial resistant <i>Enterobacteriaceae</i> among MSM using HIV pre-exposure prophylaxis (PrEP): A cross-sectional study in ItalyLeonardo Calza, Marielle Ezekielle Djusse, Claudio Foschi, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2016
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patientsLeonardo Calza, Vincenzo Colangeli, Roberto Manfredi, et al.
Pageof 19